Cargando…
The Tissue-Selective Estrogen Complex: A Review of Current Evidence
The tissue-selective estrogen complex (TSEC) has recently entered the market for the treatment of postmenopausal osteoporosis, and is particularly targeted to women with significant vasomotor symptoms. This review appraises the evidence behind the only approved TSEC to-date, a combination of bazedox...
Autores principales: | Pazhekattu, Rinu, Lau, Arthur N., Adachi, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883253/ https://www.ncbi.nlm.nih.gov/pubmed/27747497 http://dx.doi.org/10.1007/s40744-015-0013-z |
Ejemplares similares
-
Tissue-Selective Estrogen Complex and Breast
por: Lee, Dong-Yun
Publicado: (2020) -
Tissue selective estrogen complex (TSEC): a review
por: Pickar, James H., et al.
Publicado: (2018) -
Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
por: Smith, Carolyn L, et al.
Publicado: (2014) -
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
The Tissue Selective Estrogen Complex: A Promising New Menopausal Therapy
por: Komm, Barry S., et al.
Publicado: (2012)